Navigation Links
KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
Date:10/11/2007

ended March 31, 2007, and for the first quarter of fiscal 2008; (15) actions by the Securities and Exchange Commission and the Internal Revenue Service with respect to the Company's stock option grants and accounting practices; and (16) the risks detailed from time-to-time in the Company's filings with the Securities and Exchange Commission.

This discussion is by no means exhaustive, but is designed to highlight important factors that may impact the Company's outlook. We are under no obligation to update any of the forward-looking statements after the date of this release.


'/>"/>
SOURCE KV Pharmaceutical Company
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...akes it more difficult to treat the malignancy, ex...Day News) -- Women who have had their breasts augm...arly-stage breast cancer may be treated successful... as brachytherapy, according to an Arizona physici...take care of these augmented women," said Dr. Robe...
(Date:12/1/2008)...swire/ -- The next time you visit a dentist,in th...eck your blood pressure,in addition to your brush...ham Regional Medical Center/McLaren Health,Care a...heading a pilot,project designed to have dentists...ecting high blood pressure in patients. , "...
(Date:12/1/2008)...wswire-USNewswire/ -- As part of the Dec. 1 obse...th Everette James today urged Pennsylvanians to be...lso highlighted ongoing efforts to educate the pub... , "Our message is clear: regardless of your ... tested for HIV is the only sure way to know your ...
(Date:12/1/2008)...ost, non-invasive alternative to conventional angi...of having coronary artery disease; true even if th... according to a study performed at the Thomas Jeff...he study included 31 patients who had one or more ...ered during coronary CTA. Calcified plaques in the...
Breaking Medicine News(10 mins):Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 3Health News:Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease 2Health News:Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease 3Health News:PA Department of Health Recognizes 20th Anniversary of World AIDS Day; Urges HIV Testing 2
...versity of Cincinnati on skin cancers has revealed... skin cancer, and when they do get //it they are a...inned people as the diagnosis is usually done at a...d to the American Academy of Dermatology by Dr. Hu...
...g radioactive iodine dose to cure deadly brain tum...thetic scorpion venom is used as carriers for radi...ials is successfully complete and was conducted by...geon at Cedars-Sinai Medical Center's Maxine Dunit...
...mon feature among praying mantids – that is, the f...mating.// However, the possibility that males may... has never been resolved experimentally. In a pape...turalist, Jonathan Lelito and William Brown (SUNY-...
...ses of chikunguniya have been reported from across...nical and logistic support to tackle the disease /...kshmi said here today. The cases have been report...ts, she said at a review meeting with the Andhra P...
Other Medicine News:Health News:New Carrier Developed To Deliver Drugs to Gliomas 2Health News:New Carrier Developed To Deliver Drugs to Gliomas 3
(Date:11/24/2008)... Leaders of Schering-Plo...pdate for investors on the company,s research pipe... that includes 46 new entities in clinical trials ...tudies. , , "Research and development is ad... continue our transformation," said Fred Hassan, c...
(Date:11/24/2008)...ovation leadership and long-term commitment to hep...24 Schering-Plough Corpo...date on boceprevir, its lead investigational oral ...III development. The company believes boceprevir ...in-class protease inhibitor for treating chronic h...
(Date:11/24/2008)... Schering-Plough Corpora...t, its novel and selective adenosine2a receptor an...ose-finding trial in patients suffering from moder...or fluctuations and abnormal involuntary movements...today at the company,s 2008 R&D Update meeting...
(Date:11/24/2008)...24 GeneThera, Inc.,(Pin...ffering its Real Time,PCR test for Johne,s diseas... GeneThera is set to begin offering its Johne,s...09. According to GeneThera Chairman, Dr. Tony Mil... time PCR test for Johne,s disease,called HerdGu...
Breaking Medicine Technology:Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 2Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 3Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease 4GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 2GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 4Non Profit Calls on Mental Health Professionals to Honor Veterans Day by Giving an Hour of Free Counseling to Returning Veterans 5998 1Non Profit Calls on Mental Health Professionals to Honor Veterans Day by Giving an Hour of Free Counseling to Returning Veterans 5998 2New Data Presented on the Renessa 28R 29 Treatment for Female Stress Urinary Incontinence 822 1New Data Presented on the Renessa 28R 29 Treatment for Female Stress Urinary Incontinence 822 2New Data Presented on the Renessa 28R 29 Treatment for Female Stress Urinary Incontinence 822 3Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions 818 1Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions 818 2Parents survey 3A Perceptions of the duration of their childs ADHD medication 5994 1Parents survey 3A Perceptions of the duration of their childs ADHD medication 5994 2
These dual pressure sensor catheters incorporate a lumen for sampling/slow-speed injection, slow-speed injection/guide wire, or high-speed injection/guide wire. The model SPC-784A for high-speed inje
...o-Tip Pressure Catheters; Millar manufactures and ...or simultaneous high fidelity pressure measurement...sure gradients across a valve, between chambers, o...de of Polyurethane material (some include a woven ...
...ane angiography system with flexible system archit...ervention. The flexible and ergonomic architecture...ration to focus on cardiological, pediatric, and e...eration. ,AXIOM Artis dBC puts the flow into yo...
...anical catheter intended to percutaneously break-u...ccess grafts. The disposable catheter requires no ...al shaft which extends beyond the 6F plastic sheat...p spins to wipe even adherent thrombus from the gr...
Medicine Products: